Clinical Trials Logo

Clinical Trial Summary

The objective of our study is to compare the safety and effectiveness of the use of autologous cultured adipose tissue-derived stem cells versus cultured autologous chondrocytes for the treatment of chondral knee lesions.


Clinical Trial Description

Chondral knee lesions are frequent and produce important functional limitations and arthrosis development. Arthrosis is one of the most important causes of disability and its treatment with prosthetic surgery is associated with a high cost, and is not free of other complications. Several studies of cell therapy with autologous chondrocytes have shown efficacy in the treatment of this type of lesions, and currently is a common technique for the treatment of focal lesions of articular cartilage. Autologous chondrocyte transplant is associated with morbidity of the cartilage sample removal, which needs intra-articular surgery, and the limited tissue sample for culture. Adipose tissue-derived mesenchymal stem cells (ASC) have demonstrated chondrocytic differentiation and have been used in animal models for articular cartilage repair. Adipose tissue yields more ASC than chondrocytes are obtained from cartilage, and liposuction is simple and with less adverse events than arthroscopy. It is worth mentioned that culture conditions are less stringent for ASC than for chondrocytes, in terms of number of passages to obtain the amount of cells needed for implantation.

We propose a randomized clinical trial, in which we compare the surgical implantation of either autologous chondrocytes or autologous ASC to treat chondral knee lesions. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Articular Cartilage Lesion of the Femoral Condyle

NCT number NCT01399749
Study type Interventional
Source Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
Contact Alonso C. Moreno Garcia, MD
Phone +34 917277314
Email alonso.moreno.garcia@gmail.com
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date September 2011
Completion date June 2012

See also
  Status Clinical Trial Phase
Completed NCT01222559 - Efficacy and Safety Study of co.Don Chondrosphere to Treat Cartilage Defects Phase 3
Completed NCT00414700 - RCT of ChondroCelect® (in an ACI Procedure) vs Microfracture in the Repair of Cartilage Defects of the Knee Phase 3